MARINO', MICHELE Statistiche
MARINO', MICHELE
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
A case of drug-induced Graves’ Orbitopathy after combination therapy with Tremelimumab and Durvalumab
2018-01-01 Sabini, E.; Sframeli, A.; Marinò, M.
A Case of Oculocutaneous Albinism in a Patient with Hashimoto's Thyroiditis
2019-01-01 De Gennaro, Giovanni; Vitti, Paolo; Marinò, Michele
A Case of Unilateral Dermopathy Possibly Related to Graves' Disease
2019-01-01 Rodia, C.; Menconi, F.; Mazoni, L.; Torregrossa, L.; Basolo, F.; Vitti, P.; Marcocci, C.; Marino, M.
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion
2020-01-01 Giani, C.; Ramone, T.; Romei, C.; Ciampi, R.; Tacito, A.; Valerio, L.; Agate, L.; Ugolini, C.; Marino, M.; Basolo, F.; Franchi, A.; Borsari, S.; Michelucci, A.; Selli, C.; Materazzi, G.; Cetani, F.; Elisei, R.
A questionnaire survey on the management of Graves' orbitopathy in Europe
2006-01-01 Perros, P; Baldeschi, Lelio; Boboridis, K; DICKINSON A., J; Hullo, A; KAHALY G., J; KENDALL TAYLOR, P; KRASSAS G., E; LANE C., M; LAZARUS J., H; Marcocci, Claudio; Marino', Michele; MOURITS M., P; Nardi, Marco; Orgiazzi, J; Pinchera, Aldo; Pitz, S; PRUMMEL M., F; Wiersinga, W. M.
A treatment strategy for Graves' orbitopathy
2007-01-01 Marcocci, Claudio; Pinchera, Aldo; Marino', Michele
ABSENCE OF A THYROID PHENOTYPE IN SORTILIN-DEFICIENT MICE
2015-01-01 Lisi, Simonetta; Madsen, P; Botta, R; Petersen, Cm; Nykjær, A; Latrofa, Francesco; Vitti, Paolo; Marino', Michele
ABSENCE OF PRIMARY HYPOTHYROIDISM AND GOITER IN SLC26A4 (-/-) MICE FED ON A LOW IODINE DIET
2011-01-01 Calebiro, D; Porazzi, P; Bonomi, M; Lisi, S; Grindati, A; DE NITTIS, D; Fugazzola, L; Marino', Michele; Bottà, G; Persani, L.
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment?
2017-01-01 Rotondo Dottore, G.; Ionni, I.; Menconi, F.; Casini, G.; Sellari-Franceschini, S.; Nardi, M.; Vitti, P.; Marcocci, C.; Marinò, M
Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy
2004-01-01 Marocci, C; Pinchera, A; Bartalena, L; Brunetto, Mr; Morabito, Evangelia; Marinó, M.
Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with graves’ ophthalmopathy
2004-01-01 Marino', Michele; Morabito, E.; Brunetto, R. R.; Bartalena, L.; Pinchera, Aldo; Marcocci, Claudio
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy
2016-01-01 Moleti, Mariacarla; Giuffrida, Giuseppe; Sturniolo, Giacomo; Squadrito, Giovanni; Campennì, Alfredo; Morelli, Silvia; Puxeddu, Efisio; Sisti, Eleonora; Trimarchi, Francesco; Vermiglio, Francesco; Marino', Michele
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment
2022-01-01 Gallo, D.; Mortara, L.; Veronesi, G.; Cattaneo, S. A. M.; Genoni, A.; Gallazzi, M.; Peruzzo, C.; Lasalvia, P.; Moretto, P.; Bruno, A.; Passi, A.; Pini, A.; Nauti, A.; Lavizzari, M. A.; Marino, M.; Lanzolla, G.; Tanda, M. L.; Bartalena, L.; Piantanida, E.
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy
2015-01-01 Sisti, Eleonora; Coco, Barbara; Menconi, Francesca; Leo, Marenza; Rocchi, Roberto; Latrofa, Francesco; Profilo, MARIA ANTONIETTA; Mazzi, Barbara; Vitti, Paolo; Marcocci, Claudio; Brunetto, MAURIZIA ROSSANA; Marino', Michele
An update on medical management of Graves' ophthalmopathy
2005-01-01 Bartalena, L; Marcocci, Claudio; Tanda, M. L; Piantanida, E; Lai, A; Marino', Michele; Pinchera, Aldo
An update on medical management of Graves' ophthalmopathy (Review)
2005-01-01 Bartalena, L; Marcocci, Claudio; Tanda, Ml; Piantanida, E; Lai, A; Marino', Michele; Pinchera, Aldo
An update on the medical treatment of Graves' hyperthyroidism.
2014-01-01 Marino', Michele; Latrofa, Francesco; Menconi, Francesca; Chiovato, L; Vitti, Paolo
Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy
2022-01-01 Lanzolla, G; Puccinelli, L; Giudetti, M; Comi, S; Menconi, F; Maglionico, M N; Posarelli, C; Figus, M; Marcocci, C; Marino, M
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy
2016-01-01 Rotondo Dottore, Giovanna; Leo, Marenza; Casini, Giamberto; Latrofa, Francesco; Cestari, Luca; SELLARI FRANCESCHINI, Stefano; Nardi, Marco; Vitti, Paolo; Marcocci, Claudio; Marino', Michele
Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO)
2017-01-01 Rotondo Dottore, G.; Ionni, I.; Menconi, F.; Casini, G.; Sellari-Franceschini, S.; Nardi, M.; Vitti, P.; Marcocci, C.; Marino', M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A case of drug-induced Graves’ Orbitopathy after combination therapy with Tremelimumab and Durvalumab | 1-gen-2018 | Sabini, E.; Sframeli, A.; Marinò, M. | |
| A Case of Oculocutaneous Albinism in a Patient with Hashimoto's Thyroiditis | 1-gen-2019 | De Gennaro, Giovanni; Vitti, Paolo; Marinò, Michele | |
| A Case of Unilateral Dermopathy Possibly Related to Graves' Disease | 1-gen-2019 | Rodia, C.; Menconi, F.; Mazoni, L.; Torregrossa, L.; Basolo, F.; Vitti, P.; Marcocci, C.; Marino, M. | |
| A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion | 1-gen-2020 | Giani, C.; Ramone, T.; Romei, C.; Ciampi, R.; Tacito, A.; Valerio, L.; Agate, L.; Ugolini, C.; Marino, M.; Basolo, F.; Franchi, A.; Borsari, S.; Michelucci, A.; Selli, C.; Materazzi, G.; Cetani, F.; Elisei, R. | |
| A questionnaire survey on the management of Graves' orbitopathy in Europe | 1-gen-2006 | Perros, P; Baldeschi, Lelio; Boboridis, K; DICKINSON A., J; Hullo, A; KAHALY G., J; KENDALL TAYLOR, P; KRASSAS G., E; LANE C., M; LAZARUS J., H; Marcocci, Claudio; Marino', Michele; MOURITS M., P; Nardi, Marco; Orgiazzi, J; Pinchera, Aldo; Pitz, S; PRUMMEL M., F; Wiersinga, W. M. | |
| A treatment strategy for Graves' orbitopathy | 1-gen-2007 | Marcocci, Claudio; Pinchera, Aldo; Marino', Michele | |
| ABSENCE OF A THYROID PHENOTYPE IN SORTILIN-DEFICIENT MICE | 1-gen-2015 | Lisi, Simonetta; Madsen, P; Botta, R; Petersen, Cm; Nykjær, A; Latrofa, Francesco; Vitti, Paolo; Marino', Michele | |
| ABSENCE OF PRIMARY HYPOTHYROIDISM AND GOITER IN SLC26A4 (-/-) MICE FED ON A LOW IODINE DIET | 1-gen-2011 | Calebiro, D; Porazzi, P; Bonomi, M; Lisi, S; Grindati, A; DE NITTIS, D; Fugazzola, L; Marino', Michele; Bottà, G; Persani, L. | |
| Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? | 1-gen-2017 | Rotondo Dottore, G.; Ionni, I.; Menconi, F.; Casini, G.; Sellari-Franceschini, S.; Nardi, M.; Vitti, P.; Marcocci, C.; Marinò, M | |
| Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy | 1-gen-2004 | Marocci, C; Pinchera, A; Bartalena, L; Brunetto, Mr; Morabito, Evangelia; Marinó, M. | |
| Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with graves’ ophthalmopathy | 1-gen-2004 | Marino', Michele; Morabito, E.; Brunetto, R. R.; Bartalena, L.; Pinchera, Aldo; Marcocci, Claudio | |
| Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy | 1-gen-2016 | Moleti, Mariacarla; Giuffrida, Giuseppe; Sturniolo, Giacomo; Squadrito, Giovanni; Campennì, Alfredo; Morelli, Silvia; Puxeddu, Efisio; Sisti, Eleonora; Trimarchi, Francesco; Vermiglio, Francesco; Marino', Michele | |
| Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment | 1-gen-2022 | Gallo, D.; Mortara, L.; Veronesi, G.; Cattaneo, S. A. M.; Genoni, A.; Gallazzi, M.; Peruzzo, C.; Lasalvia, P.; Moretto, P.; Bruno, A.; Passi, A.; Pini, A.; Nauti, A.; Lavizzari, M. A.; Marino, M.; Lanzolla, G.; Tanda, M. L.; Bartalena, L.; Piantanida, E. | |
| Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy | 1-gen-2015 | Sisti, Eleonora; Coco, Barbara; Menconi, Francesca; Leo, Marenza; Rocchi, Roberto; Latrofa, Francesco; Profilo, MARIA ANTONIETTA; Mazzi, Barbara; Vitti, Paolo; Marcocci, Claudio; Brunetto, MAURIZIA ROSSANA; Marino', Michele | |
| An update on medical management of Graves' ophthalmopathy | 1-gen-2005 | Bartalena, L; Marcocci, Claudio; Tanda, M. L; Piantanida, E; Lai, A; Marino', Michele; Pinchera, Aldo | |
| An update on medical management of Graves' ophthalmopathy (Review) | 1-gen-2005 | Bartalena, L; Marcocci, Claudio; Tanda, Ml; Piantanida, E; Lai, A; Marino', Michele; Pinchera, Aldo | |
| An update on the medical treatment of Graves' hyperthyroidism. | 1-gen-2014 | Marino', Michele; Latrofa, Francesco; Menconi, Francesca; Chiovato, L; Vitti, Paolo | |
| Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy | 1-gen-2022 | Lanzolla, G; Puccinelli, L; Giudetti, M; Comi, S; Menconi, F; Maglionico, M N; Posarelli, C; Figus, M; Marcocci, C; Marino, M | |
| Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy | 1-gen-2016 | Rotondo Dottore, Giovanna; Leo, Marenza; Casini, Giamberto; Latrofa, Francesco; Cestari, Luca; SELLARI FRANCESCHINI, Stefano; Nardi, Marco; Vitti, Paolo; Marcocci, Claudio; Marino', Michele | |
| Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO) | 1-gen-2017 | Rotondo Dottore, G.; Ionni, I.; Menconi, F.; Casini, G.; Sellari-Franceschini, S.; Nardi, M.; Vitti, P.; Marcocci, C.; Marino', M. |